Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.7M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
21.3M
-
Shares change
-
-192K
-
Total reported value, excl. options
-
$54.2M
-
Value change
-
-$519K
-
Number of buys
-
20
-
Number of sells
-
-24
-
Price
-
$2.55
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2017
63 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q2 2017.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.3M shares
of 44.7M outstanding shares and own 47.6% of the company stock.
Largest 10 shareholders include First Light Asset Management, LLC (3.57M shares), HEARTLAND ADVISORS INC (2.1M shares), DIMENSIONAL FUND ADVISORS LP (1.71M shares), ROYCE & ASSOCIATES LP (1.56M shares), BlackRock Inc. (1.55M shares), VANGUARD GROUP INC (1.54M shares), Glacier Peak Capital LLC (1.32M shares), SEGALL BRYANT & HAMILL, LLC (781K shares), ACADIAN ASSET MANAGEMENT LLC (736K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (706K shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.